Softness Indicates Metastatic Cells

The tenderness of cancer cells squeezed by a special apparatus can help pinpoint the ones most likely to spread the disease.

Written byEdyta Zielinska
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

An atomic force microscope with a microscale cantilever, and a petri dish of ovarian cancer cells.Georgia Institute of Technology, Rob FeltResearchers were able to use cell stiffness to differentiate between metastatic ovarian cancer cells and those that were less likely to spread and grow in new locations. Examining a cell line known to be highly metastatic and one that rarely metastasizes, the researchers measured the cells’ pliability by tapping them using a microscopic probe and an atomic force microscope, and accurately predicted which cell line it came from, with cells of the metastatic line being consistently softer. The researchers say that the study, published earlier this month (October 4) in the journal PLOS ONE, could one day help doctors choose more or less aggressive treatment depending on whether the cancer is metastatic or not.

The finding makes sense, said author Todd Sulchek from Georgia Institute of Technology in a press release. “In order to spread, metastatic cells must push themselves into the bloodstream. As a result, they must be highly deformable and softer.”

According to the authors, if the technology is developed further, and validated for other cancer types, it could prove a useful biomarker for finding cells with high metastatic potential.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies